Evidence map›Paper›PMID 31882001›Full record

ArticleAddiction science & clinical practice2019

Building a Group-Based Opioid Treatment (GBOT) blueprint: a qualitative study delineating GBOT implementation.

Randi Sokol, Mark Albanese, Aaronson Chew, Jessica Early, Ellie Grossman, David Roll, Greg Sawin, Dominic J Wu, Zev Schuman-Olivier

Abstract read
In one paragraph

Article in Addiction science & clinical practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Assessing the feasibility, usability and acceptability of theDrug and alcohol dependence reports · 2022
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Randi SokolMalden Family Medicine Center, 195 Canal St, Malden, MA, 02148, USA. rsokol@challiance.org.
Mark AlbaneseOutpatient Addiction Services, 26 Central St, Somerville, MA, 02143, USA.
Aaronson ChewMalden Family Medicine Center, 195 Canal St, Malden, MA, 02148, USA.
Jessica EarlyMalden Family Medicine Center, 195 Canal St, Malden, MA, 02148, USA.
Ellie GrossmanSomerville Hospital Primary Care, 236 Highland Avenue, Somerville, MA, 02143, USA.
David RollRevere Care Center, 454 Broadway, Revere, MA, 02151, USA.
Greg SawinMalden Family Medicine Center, 195 Canal St, Malden, MA, 02148, USA.
Dominic J WuMalden Family Medicine Center, 195 Canal St, Malden, MA, 02148, USA.
Zev Schuman-OlivierCenter for Mindfulness and Compassion, 1035 Cambridge Street, Suite 21, Cambridge, MA, 02141, USA.

Funding

Remotely-Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance UseR33AT010125 · NCCIH · CAMBRIDGE HEALTH ALLIANCE · PI SCHUMAN OLIVIER, ZEV DAVID · 2019 to 2022
$3.0M
Effect of Mindfulness Training on Opioid Use and Anxiety During Primary Care Buprenorphine TreatmentR21AT010125 · NCCIH · CAMBRIDGE HEALTH ALLIANCE · PI SCHUMAN OLIVIER, ZEV DAVID · 2018 to 2018
$328k
NCCIH NIH HHS R21 AT010125NCCIH NIH HHS R33 AT010125
6 · The paper itself

Abstract

backgroundGroup-Based Opioid Treatment (GBOT) has recently emerged as a mechanism for treating patients with opioid use disorder (OUD) in the outpatient setting. However, the more practical "how to" components of successfully delivering GBOT has received little attention in the medical literature, potentially limiting its widespread implementation and utilization. Building on a previous case series, this paper delineates the key components to implementing GBOT by asking: (a) What are the core components to GBOT implementation, and how are they defined? (b) What are the malleable components to GBOT implementation, and what conceptual framework should providers use in determining how to apply these components for effective delivery in their unique clinical environment?

methodsTo create a blueprint delineating GBOT implementation, we integrated findings from a previously conducted and separately published systematic review of existing GBOT studies, conducted additional literature review, reviewed best practice recommendations and policies related to GBOT and organizational frameworks for implementing health systems change. We triangulated this data with a qualitative thematic analysis from 5 individual interviews and 2 focus groups representing leaders from 5 different GBOT programs across our institution to identify the key components to GBOT implementation, distinguish "core" and "malleable" components, and provide a conceptual framework for considering various options for implementing the malleable components.

resultsWe identified 6 core components to GBOT implementation that optimize clinical outcomes, comply with mandatory policies and regulations, ensure patient and staff safety, and promote sustainability in delivery. These included consistent group expectations, team-based approach to care, safe and confidential space, billing compliance, regular monitoring, and regular patient participation. We identified 14 malleable components and developed a novel conceptual framework that providers can apply when deciding how to employ each malleable component that considers empirical, theoretical and practical dimensions.

conclusionWhile further research on the effectiveness of GBOT and its individual implementation components is needed, the blueprint outlined here provides an initial framework to help office-based opioid treatment sites implement a successful GBOT approach and hence potentially serve as future study sites to establish efficacy of the model. This blueprint can also be used to continuously monitor how components of GBOT influence treatment outcomes, providing an empirical framework for the ongoing process of refining implementation strategies.

Indexed as

ConfidentialityGroup ProcessesHumansOpioid-Related DisordersPatient Care TeamPatient ParticipationPsychotherapy, GroupQualitative ResearchBuprenorphine–naloxoneGBOTGroup psychotherapyGroup visitImplementation scienceShared medical appointment

Identifiers

PMID31882001
PMCPMC6935085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.